Oncology & Cancer

Metformin linked to lower risk of head, neck cancer

(HealthDay)—Metformin is associated with a lower risk of developing head and neck cancer in patients with diabetes, according to a study published in the September issue of Head & Neck.

Oncology & Cancer

Hearing loss and tinnitus are common in cancer survivors

While children receiving chemotherapy routinely undergo hearing tests, adults don't, and a new study by UC San Francisco reports for the first time that significant hearing issues often occur among adult survivors of the ...

Oncology & Cancer

Certain cancer treatment plans linked to delays

Patients undergoing primary radiotherapy treatment with or without chemotherapy, rather than surgery, for head and neck cancers are more likely to experience delays in their treatment starting, according to a new analysis ...

page 30 from 40